Innovation Fund

Selected news for the capital firm - Innovation Fund, collected since 10/2017. This capital firm shares healthcare news with Merck, Digital Health, AristaMD, COVID-19, MemorialCare and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers healthcareittoday.com ... Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.This round brings Transcarent’s total funding raised to $298 million in just over one year and highlights the growing demand from self-insured employers for ...
1/11/2022 PreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry Leaders to Commercialize Cancer Risk Stratification Services to Support Better Patient Insights and Outcomes PR Newswire ... years of executive leadership, product commercialization, and operations experience to the Company, including management positions at MedTest, Wheaton Industries / DWK, Synthon Pharmaceuticals, and Becton Dickinson .The round was led by the Merck Global Health Innovation Fund (Merck GHI) with additional investment from a number of healthcare leaders and innovators, including Mount Sinai Health System, Agilent Technologies, IBM Ventures, and the Hobart Group. The funding will be used to support the ...
1/11/2022 malvern-online.com ... Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005556/en/This round brings Transcarent’s total funding raised to $298 ...
1/11/2022 California investor buys Medtronic campus in Gunbarrel bizwest.com ... over a year ago.Texas investment group Crescent Real Estate LLC, which bought the campus in December 2020 for $36.5 million through holding company GPIF MT Boulder LLC — the GPIF stands for GP Innovation Fund s, a unit formed after the 2016 combination of Crescent Real Estate Holdings and Goff Capital Partners — sold the site to 5920 Boulder LLC, an entity registered to the San Mateo, California address of ...
1/11/2022 Transcarent Raises $200M for Care Platform for Self-Insured Employers HIT Consultant ... Group and leading health systems including Northwell Health , Intermountain Healthcare , and Rush University Medical Center .– The funding round also included participation from existing investors, including General Catalyst , 7wireVentures , Alta Partners , Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures , and GreatPoint Ventures . This round brings Transcarent’s total funding to $298 million in just over one year.On-Ramp for Self-Insured Employers and their EmployeesHealth systems ...
1/11/2022 Transcarent secures $200M to expand into new markets Modern Healthcare ... opinions, previously raised $98 million in the year since its launch .The latest round was led by Kinnevik and Human Capital, and includes Ally Bridge Group, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures and GreatPoint Ventures.Transcarent is led by former Livongo CEO Glen Tullman , which was acquired by Teladoc in late 2020 for $18.5 billion.The company plans on expanding into ...
1/11/2022 Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers | News | bakersfield.com bakersfield.com ... Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005556/en/This round brings Transcarent’s total funding raised to $298 ...
1/11/2022 Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers | Business | The Daily News galvnews.com ... Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005556/en/This round brings Transcarent’s total funding raised to $298 ...
1/11/2022 Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers repertoiremag.com ... Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.“At Transcarent, we’ve created a new and different health and care experience that puts consumers back in charge and is simply better aligned for employers ...
1/11/2022 Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers jhconline.com ... Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund , Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.“At Transcarent, we’ve created a new and different health and care experience that puts consumers back in charge and is simply better aligned for employers ...
1/11/2022 Digital Health Startup Transcarent Just Raised $200 Million To Grow Its Concierge Medical Business Forbes ... investors participated in this round, including General Catalyst, GreatPoint Ventures, Threshold Ventures, Alta Partners, Jove Equity Partners, Lee Shapiro, managing partner of 7wireVentures (where Tullman is founder and managing partner) and Merck Global Health Innovation Fund . Joining this round are investors Ally Bridge Group and several healthcare systems, including Rush University Medical Center, Northwell Health, and Intermountain Healthcare.Christian Scherrer, an investment manager at Kinnevik, whose firm had also invested ...
1/10/2022 DEBIOPHARM INVESTS IN VERISIM LIFE'S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH Yahoo News ... to invest in digital health solutions that improve the cancer patient journey, transform pharmaceutical R&D, and shift healthcare towards a more patient-centric approach.With the financing round led by Morpheus Ventures, Debiopharm Innovation Fund joins new investors including Colorcon Ventures along with existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures. Founded in 2017 by Jo Varshney , DVM and PhD alongside a cross-functional team of ...
1/10/2022 DEBIOPHARM INVESTS IN VERISIM LIFE'S $15M SERIES A ROUND TO ADVANCE AI-ENABLED DRUG RESEARCH Yahoo News ... to invest in digital health solutions that improve the cancer patient journey, transform pharmaceutical R&D, and shift healthcare towards a more patient-centric approach.With the financing round led by Morpheus Ventures, Debiopharm Innovation Fund joins new investors including Colorcon Ventures along with existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures. Founded in 2017 by Jo Varshney , DVM and PhD alongside a cross-functional team of ...
1/6/2022 VeriSIM Life Secures $15 Million Series A Funding Business Wire ... unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round. The financing was led by Morpheus Ventures. Additional new investors include Debiopharm Innovation Fund and Colorcon Ventures, with continued support from existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005112/en ...
1/6/2022 VeriSIM Life Secures $15 Million Series A Funding | Business | Maryville Daily Forum maryvilleforum.com ... unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round. The financing was led by Morpheus Ventures. Additional new investors include Debiopharm Innovation Fund and Colorcon Ventures, with continued support from existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005112/en ...
1/6/2022 VeriSIM Life Secures $15 Million Series A Funding | Business & Finance | citizentribune.com citizentribune.com ... unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round. The financing was led by Morpheus Ventures. Additional new investors include Debiopharm Innovation Fund and Colorcon Ventures, with continued support from existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005112/en ...
1/6/2022 VeriSIM Life Secures $15 Million Series A Funding | News | bakersfield.com bakersfield.com ... unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round. The financing was led by Morpheus Ventures. Additional new investors include Debiopharm Innovation Fund and Colorcon Ventures, with continued support from existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005112/en ...
1/6/2022 VeriSIM Life Secures $15 Million Series A Funding | Business | The Daily News galvnews.com ... unique R&D decisions de-risker for breakthrough drug development, today announced it has closed its oversubscribed $15 million Series A round. The financing was led by Morpheus Ventures. Additional new investors include Debiopharm Innovation Fund and Colorcon Ventures, with continued support from existing investors OCA Ventures, Intel Capital, Serra Ventures and Susa Ventures.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005112/en ...
1/4/2022 HITLAB Hosts 40th annual January Digital Health Symposium to Review Insights from J.P. Morgan Healthcare Conference thepilotnews.com ... investment, and a forecast for digital health in 2022.Attendees will have the opportunity to network and learn from leaders including but not limited to:Shiva Rajgopal , Professor, Columbia Business School Merck Global Health Innovation Fund AARP Innovation Lab OPTT Sana Entrée Capital Speakers will address topics such as:Healthcare Commerce and investingDigital Health tools, apps and devicesHealth trackingPersonalized medicineHealthcare equity and accessThe three ...
12/28/2021 Follow the Money: AI-Driven Talent Engagement, Cancer Center Funding, Maternal Health, More bio-itworld.com ... financing round, bringing the total funding to date to $131 million. The financing round was led by RA Capital Management and included participation from new investors the D.E. Shaw group, Senvest, InCube, and SVB Innovation Fund , as well as existing investors Foresite Capital, Hambrecht Ducera Growth Ventures, J2V, Cedars-Sinai, and Merck GHIF. Tasso will use the proceeds from the latest funding round to scale manufacturing and operations to meet ...